Literature DB >> 31685365

When only one embryo is available, is it better to transfer on Day 3 or to grow on?

Joyce S Xiao1, Martin Healey2, Alon Talmor3, Beverley Vollenhoven4.   

Abstract

RESEARCH QUESTION: In patients with only one embryo on Day 3 post-IVF treatment, does transferring the embryo into the uterine environment achieve a higher pregnancy rate than growing the embryo on with a plan to transfer at Day 4-6?
DESIGN: This was a retrospective cohort study conducted in patients with only one viable embryo on Day 3 post-IVF treatment. Data were extracted from a standardized IVF database and included 1384 women who fulfilled this study's selection criteria. Outcomes of these embryos were followed up and stratified into two groups: embryos transferred on Day 3 and those grown on to Day 4-6. Pregnancy rate (biochemical and clinical) and live birth rates were analysed with logistic regression and adjusted using a parsimonious model for baseline patient characteristics.
RESULTS: Biochemical pregnancy (16.7% versus 9.5%, odds ratio [OR] 1.9, P = 0.001), clinical pregnancy (14.7% versus 6.8%, OR 2.35, P < 0.001) and live birth rates (9.7% versus 4.4%, OR 2.37, P = 0.002) were significantly higher in the Day 3 group than those in the group grown on to Day 4-6. These differences were still significant after adjusting for potential confounders (adjusted OR 2.60, 3.71, 4.08, respectively, P < 0.001).
CONCLUSIONS: These findings support Day 3 cleavage-stage embryo transfer instead of growing on to Day 4-6 for blastocyst-stage transfer when only a single embryo is available.
Copyright © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blastocyst; Cleavage-stage embryo; Embryo transfer; IVF; Live birth; Pregnancy rate

Mesh:

Year:  2019        PMID: 31685365     DOI: 10.1016/j.rbmo.2019.08.003

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  9 in total

1.  Why is use of donor eggs not viewed as treatment failure? A call for improvements in treatments with autologous oocytes.

Authors:  Norbert Gleicher; David H Barad; Eli Y Adashi
Journal:  J Assist Reprod Genet       Date:  2020-06-06       Impact factor: 3.412

2.  Blastocyst versus cleavage transfers: who benefits?

Authors:  Enver Kerem Dirican; Safak Olgan; Mehmet Sakinci; Mete Caglar
Journal:  Arch Gynecol Obstet       Date:  2021-09-06       Impact factor: 2.344

3.  A stepwise approach to move from a cleavage-stage to a blastocyst-stage transfer policy for all patients in the IVF clinic.

Authors:  I De Croo; P De Sutter; K Tilleman
Journal:  Hum Reprod Open       Date:  2020-09-22

4.  Improved clinical outcomes after non-invasive oocyte selection and Day 3 eSET in ICSI patients.

Authors:  Inge Van Vaerenbergh; Tom Adriaenssens; Wim Coucke; Lisbet Van Landuyt; Greta Verheyen; Michaël De Brucker; Michel Camus; Peter Platteau; Michel De Vos; Elien Van Hecke; André Rosenthal; Johan Smitz
Journal:  Reprod Biol Endocrinol       Date:  2021-02-19       Impact factor: 5.211

5.  Is there still a role for a cleavage-stage embryo transfer?

Authors:  Michael F Neblett; Tana Kim; Tiffanny L Jones; Sarah C Baumgarten; Charles C Coddington; Yulian Zhao; Chandra C Shenoy
Journal:  F S Rep       Date:  2021-06-29

Review 6.  Revisiting selected ethical aspects of current clinical in vitro fertilization (IVF) practice.

Authors:  Anja von Schondorf-Gleicher; Lyka Mochizuki; Raoul Orvieto; Pasquale Patrizio; Arthur S Caplan; Norbert Gleicher
Journal:  J Assist Reprod Genet       Date:  2022-02-22       Impact factor: 3.412

7.  Cleavage-stage human embryo arrest, is it embryo genetic composition or others?

Authors:  Raoul Orvieto; Anat Jonish-Grossman; Sharon Avhar Maydan; Meirav Noach-Hirsh; Olga Dratviman-Storobinsky; Adva Aizer
Journal:  Reprod Biol Endocrinol       Date:  2022-03-17       Impact factor: 5.211

8.  No difference in cumulative live birth rates between cleavage versus blastocyst transfer in patients with four or fewer zygotes: results from a retrospective study.

Authors:  I De Croo; R Colman; P De Sutter; D Stoop; K Tilleman
Journal:  Hum Reprod Open       Date:  2022-07-22

9.  Time associations between U.S. birth rates and add-Ons to IVF practice between 2005-2016.

Authors:  Norbert Gleicher; Lyka Mochizuki; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2021-07-13       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.